William H Rastetter's Net Worth
$31.6 Million
Who is William H Rastetter?
William H Rastetter has an estimated net worth of $31.6 Million. This is based on reported shares across multiple companies, which include NEUROCRINE BIOSCIENCES INC, Receptos, Inc., FATE THERAPEUTICS INC, Dare Bioscience, Inc., Regulus Therapeutics Inc., BIOGEN IDEC INC, and ILLUMINA INC.
SEC CIK
William H Rastetter's CIK is 0001205903
Past Insider Trading and Trends
2004 was William H Rastetter's most active year for acquiring shares with 18 total transactions. William H Rastetter's most active month to acquire stocks was the month of April. 2004 was William H Rastetter's most active year for disposing of shares, totalling 17 transactions. William H Rastetter's most active month to dispose stocks was the month of April. 2013 saw William H Rastetter paying a total of $1,199,535.42 for 318,334 shares, this is the most they've acquired in one year. In 2015 William H Rastetter cashed out on 67,600 shares for a total of $8,955,481.98, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
NEUROCRINE BIOSCIENCES INC (NBIX) Snapshot price: $120.17
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -27.54% | -14.25K |
$146.69 | -$2,090,332.50 | 37.49K |
Aug 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
| +20.93% | 8.96K |
$72.22 | -$1,192,327.07 | 51.74K |
Scheduled
|
Jan 2
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
| +8.43% | 3.33K |
$57.07 | -$339,221.49 | 42.78K |
May 1
| |||
Form 4
| +15.98% | 5.44K |
$58.87 | -$571,318.98 | 39.46K |
Apr 19 - Apr 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
| +37.46% | 9.27K |
$50.80 | -$885,166.13 | 34.02K |
Scheduled
|
Apr 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
| +73.68% | 10.5K |
$48.53 | -$714,000.00 | 24.75K |
Scheduled
|
Jan 24
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
∞
| 14.25K |
$22.23 | -$400,260.00 | 14.25K |
Scheduled
|
Feb 1
| ||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Receptos, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -339.63K |
—
|
—
|
0
|
Aug 25 - Aug 27
| |||
Form 4
|
∞
| 7.4K |
—
|
—
| 7.4K |
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
| -2.86% | -37.36K |
$30.85 | -$1,152,525.15 | 1.27M |
Jan 3
| |||
Form 4
| -2.07% | -27.58K |
$30.29 | -$835,428.49 | 1.31M |
Jan 2
| |||
Form 4
| -27.28% | -500.00K |
$27.63 | -$13,815,000.00 | 1.33M |
Dec 5
| |||
Form 4
| -12.00% | -250.00K |
$22.05 | -$5,512,500.00 | 1.83M |
Nov 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 17
| |||
Form 4
| +1,141.29% | 2.22M |
$9.10 | $16,138,405.48 | 2.41M |
May 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
FATE THERAPEUTICS INC (FATE) Snapshot price: $3.41
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
| +322.64% | 8.65K |
—
|
—
| 11.33K |
Jun 9
| |||
Form 4
|
∞
| 2.68K |
—
|
—
| 2.68K |
Jun 2
| |||
Form 4/A
|
—
|
0
|
—
|
—
| 146.82K |
Mar 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
|
∞
| 28.46K |
$1.37 | $38,991.57 | 28.46K |
Mar 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 2
| |||
Form 4
| +451.13% | 375.94K |
$2.66 | $999,997.74 | 459.27K |
Nov 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
∞
| 83.33K |
$6.00 | $499,998.00 | 83.33K |
Oct 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Dare Bioscience, Inc. (DARE) Snapshot price: $3.6
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 10
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jul 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 19
| |||
Form 4
| +30.94% | 24.35K |
$0.77 | $18,749.50 | 103.04K |
Jan 3
| |||
Form 4
| +30.48% | 18.38K |
$1.02 | $18,749.64 | 78.69K |
Oct 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 26
| |||
Form 4
| +145.54% | 60.31K |
$7.00 | $132,083.00 | 101.75K |
Apr 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Regulus Therapeutics Inc. (RGLS) Snapshot price: $1.48
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
| +137.23% | 225.94K |
—
|
—
| 390.58K |
Feb 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 10
| |||
Form 4/A
| +151.45% | 92.89K |
$1.08 | $100,320.12 | 154.22K |
May 7
| |||
Form 4
| +151.45% | 92.89K |
$1.08 | $100,320.12 | 154.22K |
May 7
| |||
Form 4
| +41.23% | 23.26K |
—
|
—
| 79.67K |
Nov 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
| +11.15% | 69.66K |
$0.89 | $61,999.18 | 694.39K |
Dec 4
| |||
Form 4
| +78.52% | 274.73K |
$0.91 | $249,999.75 | 624.63K |
Jul 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
| +250.00% | 250K |
$1.15 | $287,500.00 | 350K |
Mar 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
∞
| 100K |
$10.17 | $1,016,977.58 | 100K |
Jul 20 - Jul 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||